Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Eaton Vance Ohio Municipal Income Trust (NQ: EVO )

7.650 +0.290 (+3.94%)
Streaming Delayed Price Updated: 3:59 PM EDT, Apr 23, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 33,841
Open 7.580
Bid (Size) 7.620 (2)
Ask (Size) 7.800 (1)
Prev. Close 7.360
Today's Range 7.570 - 7.770
52wk Range 6.834 - 13.49
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Evotec SE appoints Dr Christian Wojczewski as Chief Executive Officer
Via ACCESSWIRE
Evotec and Variant Bio Enter Strategic Partnership to Discover and Develop Fibrosis Treatments
Via ACCESSWIRE

Performance

YTD
-32.89%
-32.89%
1 Month
+4.51%
+4.51%
3 Month
-7.94%
-7.94%
6 Month
-11.76%
-11.76%
1 Year
-21.94%
-21.94%

More News

Read More
Evotec SE to Announce Results for Fiscal Year 2023 on 24 April 2024
Via ACCESSWIRE
Evotec welcomes Aurélie Dalbiez as Chief People Officer
Via ACCESSWIRE
Finding the Next Big Winners: 7 Stocks You Can Snag for Under $10
Via InvestorPlace
Evotec SE: Invitation to Conference Call
Via ACCESSWIRE
3 Stocks Set to Double: Your Fast Track to 2024 Gains
Via InvestorPlace
Evotec And Claris Ventures Streamline Access to Accelerate Programmes from Claris's Portfolio Companies into The Clinic
Via ACCESSWIRE
7 Stable Stocks to Buy for 100% Returns by 2025
Via InvestorPlace
The Next Johnson & Johnson? 3 Healthcare Stocks That Investors Shouldn’t Ignore.
Via InvestorPlace
Just - Evotec Biologics Expands Development and Manufacturing Agreement with ABL for Broadly Neutralising Antibodies Against HIV
Via ACCESSWIRE
What's Going On With Life Science Company Evotec Stock Today?
Via Benzinga
Evotec and Crohn's & Colitis Foundation Enter Agreement to Advance Drug Discovery for Novel IBD Therapies
Via ACCESSWIRE
Evotec Announces Progress in Strategic Neuroscience Partnership with Bristol Myers Squibb
Via ACCESSWIRE
Why Mobileye Global Shares Are Trading Lower By Over 23%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Why Is Mobileye (MBLY) Stock Down 26% Today?
Via InvestorPlace
Can TikTok Save Peloton (PTON) Stock?
Via InvestorPlace
Why Is Evotec (EVO) Stock Down 12% Today?
Via InvestorPlace
Why Resources Connection Shares Are Trading Higher By Over 6%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Via InvestorPlace
Why Germany-Based Life Science Company Evotec Shares Are Falling Today
Via Benzinga
Cal-Maine Posts Downbeat Q2 Results, Joins Dyne Therapeutics, OPKO Health And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
Via Benzinga
Topics Stocks
Exposures US Equities
Evotec and Owkin Enter an A.I.-Powered Strategic Partnership to Accelerate Therapeutics Pipeline in Oncology and I&I
Via ACCESSWIRE
Evotec Announces CEO Transition
Via ACCESSWIRE
Evotec receives US$ 2.5 M Grant to Leverage Human iPSC-Derived Teratogenicity Platform for Global Health Programmes
Via ACCESSWIRE
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.